Main content
Could a new drug help women with Ovarian cancer?
Ovarian Cancer rates in the UK are amongst the highest in Europe, yet has one of the lowest survival rates. But a new drug, Niraparib, is becoming available in England today and in Wales within the next few weeks, with the aim to provide patients with more time chemo-free. Professor of Medical Oncology, Dr Jonathan Ledermann and ovarian cancer patient, Vanessa Hillary discuss the impact it could have.
Duration:
This clip is from
Featured in...
Listen—Woman's Hour
Catch up with the best from Woman's Hour here.
More clips from Chelsea Clinton
-
Growing up in the White House
Duration: 07:59
More clips from Woman's Hour
-
‘It is a crisis that is not serving our children’s needs’
Duration: 01:49
-
Kate McKinnon: ‘I’ve been profoundly weird my whole life’
Duration: 01:40